Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast

Core Insights - Co-Diagnostics, Inc. will release its second quarter 2024 financial results on August 8, 2024, after market close [1] - A conference call and webcast will be held on the same day at 4:30 p.m. ET to discuss the financial results with analysts and institutional investors [1] - Key management participating in the call includes CEO Dwight Egan, CFO Brian Brown, and Head of Investor Relations Andrew Benson [1] Company Overview - Co-Diagnostics, Inc. is a molecular diagnostics company based in Utah, specializing in the development, manufacturing, and marketing of advanced diagnostic technologies [3] - The company's technologies focus on tests that detect and analyze nucleic acid molecules (DNA or RNA) [3] - Co-Diagnostics utilizes proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform, as well as to identify genetic markers for various applications beyond infectious diseases [3]